Astria Therapeutics
ATXS
ATXS
24 hedge funds and large institutions have $10.4M invested in Astria Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.1% less ownership
Funds ownership: 0.65% → 0.55% (-0.1%)
11% less capital invested
Capital invested by funds: $11.8M → $10.4M (-$1.35M)
Holders
24
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$271K | |
| 2 | +$91K | |
| 3 | +$68K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$48K |
| 5 |
OC
Oppenheimer & Co
New York
|
+$42.3K |
Top Sellers
| 1 | -$187K | |
| 2 | -$162K | |
| 3 | -$142K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$45K |
| 5 |
Goldman Sachs
New York
|
-$31K |